“We’re on the Cusp of a Worldwide Explosion” ~ U.S. Health Dept.

California Biotech
Cleared to Bypass
FDA – Next Month –
for 22,627% Gains

Company’s new “Bio Seeds” could cure eight
diseases, including cancer and diabetes…

Breakthrough set to storm 64 world markets,
sparking cash windfall worth $497.8 billion…

Dear Reader,

Six weeks from today, one tiny biotech company could make medical history.

It could also make some smart investors very rich.

No, the company hasn’t found another “miracle cure” for cancer.

Nor has it created a “magic pill” for treating diabetes…

This isn’t a new cure for heart disease… Alzheimer’s… arthritis… kidney failure… Parkinson’s… or macular degeneration…

It’s a single remedy that promises permanent cures for all eight of these devastating conditions.

The Centers for Disease Control calls this breakthrough “the next evolution in medical treatments.”

And an open letter to President Obama, signed by such notable experts as Dr. Elias Corey of Harvard Medical School, says:

“The landscape of diseases and medical research problems potentially benefiting from this is broad and significant.”

So how can one product cure so many different diseases?

You’ll discover exactly how in the next five minutes.

Along the way, you’ll learn how the company behind this breakthrough will sidestep the FDA – legally – next month.

Once that happens, the product will storm an estimated 64 major markets at once. They include the United States, Great Britain, China, India, Canada and Russia.

According to estimates from the conservative U.S. Health Dept., the coming event will spark a $497.8 billion cash explosion. And gains could exceed 22,627% for investors who get in beforehand.

Here’s everything you need to know to take full advantage of this remarkable opportunity…

“Virtually any disease may be potentially cured”
~ U.S. Health Dept.

For thousands of years, doctors have primarily relied on drugs and surgery to treat diseases.

But one tiny company has discovered an entirely new approach. Instead of treating diseases, this new “medicine” promises to cure them entirely.

How?

The company’s new technology produces synthetic human cells in the laboratory – on demand.

Doctors can use these cells – “Bio Seeds” – to replace damaged tissue anywhere in the body.

As the U.S. Health & Human Service Dept. (HHS) reports:

“This revolutionary technology has the potential to develop therapies for previously untreatable diseases… virtually any disease that results from malfunctioning, damaged, or failing tissues may be potentially cured.”

But how exactly could “Bio Seeds” revolutionize modern medicine starting within the next six weeks?

Let’s take a closer look…

Eight Major Diseases… One Common Cure?

By replacing diseased cells in the body, these synthetic cells have the power to erase even the deadliest diseases forever…

Imagine cancer… heart disease… diabetes and more… wiped out like polio…

Heart Disease… GONE! After heart attacks, doctors can simply replace the damaged part of the heart with fresh, new cells. Within 60 days, the patient’s heart regenerates itself – and begins functioning like new! No maintenance drugs. No decrease in life expectancy.

Diabetes… GONE! Replenished with new “replacement” cells, the patient’s pancreas produces insulin again on its own. No more shots, drugs, or special diets!

Cancer… GONE! Instead of radiation or chemo, doctors just replace the affected body part with tissue developed from “Bio Seeds.”

Instead of “treating” diseased tissues with drugs and surgery, doctors will replace them with synthetic cells.

The industry term for this cell-replacement approach is “regenerative medicine.”

Let’s take a closer look at how this breakthrough could soon make investors sizable gains…

The Next Revolution in Modern Medicine

According to the U.S. Dept. of Health & Human Services (HHS):

“This new field holds the realistic promise of regenerating damaged tissues and organs in vivo (in the living body) through reparative techniques that stimulate previously irreparable organs into healing themselves.

“Regenerative medicine also empowers scientists to grow tissues and organs in vitro (in the laboratory) and safely implant them when the body is unable to be prompted into healing itself.”

The National Institutes of Health calls regenerative medicine “a rapidly developing field with the potential to transform the treatment of human disease.”

But could cell-replacement really hand some investors 22,627% gains starting six weeks from now?

Consider…

One Tiny Market…
Poised to Explode

Around the world, doctors have begun small-scale tests using replacement cells.

The early results have been amazing.

• Already, engineered bladder cells can be grown outside the patient’s body and transplanted successfully, according to the National Institutes of Health.
• Doctors have grown replacement skin to cover wounds and burns, and to treat diabetic ulcers… They’ve grown human fingers from “replacement cells.”
• They’ve even used “replacement cells” to grow whole organs in the laboratory. As “60 Minutes” reported recently, “Researchers have created beating hearts, ears and bladders by manipulating cells in the human body into re-growing tissue.”

Last year, for example, University of Pittsburgh’s Dr. Stephen Badylak grew a replacement esophagus for cancer patient Irwin Schmidt. Today, Schmidt functions 100% normally, with his new esophagus. He remains disease free.

The list of such early successes goes on.

Yet according to Life Science Intelligence, “The actual current market represents only a fraction of the potential market.”

Indeed, the regenerative-medicine market stands at just $2.2 billion. But according to the U.S. Health Dept. report “A New Vision,” this new medical market is about to explode by an additional $497.8 billion… to $500 billion dollars!

Do the math and you’re looking at a 22,627% growth boom, starting next month!

Billions of dollars have already begun pouring in ahead of the big event…

Billions of Dollars, Flooding in Already

The state of California has approved $3 billion for regenerative-medicine research.

New York, Maryland, Illinois, Massachusetts and other states are following suit, too.

Sloan-Kettering Institute… Stanford University School of Medicine… Harvard Stem Cell Institute… the McGowan Institute for Regenerative Medicine at the University of Pittsburgh… the list of big institutions jumping onboard goes on.

But the really big money could come from Big Pharma.

Pfizer, Merck and other major drug companies have committed hundreds of millions already.

So how is one company going to fuel the coming revolution?

By supplying all these researchers with the actual replacement cells they need to create the regenerative medicines of tomorrow…

We recently flew 3,000 miles to meet the man behind this incredible breakthrough.

Unless you work in the medical-research field, you don’t likely know his name. So we’ll just call him “Doctor X.”

He founded and currently heads the company behind “Bio Seeds.”

And what he revealed during our private meeting at the San Francisco Hilton could soon make investors very, very rich…

How One Company Will Spark the Coming Boom

Within the next six weeks, “Bio Seeds” are set to storm dozens of medical markets around the world.

Doctors will be able to use these “Bio Seeds” to create cures for heart disease… diabetes… cancer… Alzheimer’s… Parkinson’s… arthritis… kidney failure and macular degeneration.

As the doctor says:

“The great scientific interest lies in the potential of [“Bio Seeds”] to transform into any cell type of the human body. These cells therefore show considerable potential as a source of new therapies for a host of currently-incurable diseases such as: diabetes, Alzheimer’s and Parkinson’s disease, heart failure, arthritis, as well as many other disorders that may be treated by replacing diseased or damaged organ tissues.”

Just a few examples of these breakthrough “Bio Seeds”…

The company’s XJJ-30 “Bio Seeds” sprout into fresh heart cells…

Its new 40W “Bio Seeds” grow into fresh kidney cells…

And the 4JF cells are designed to cure Parkinson’s…

“These cells have the potential to make everything in the human body… even on a commercial scale,” says Doctor X.

And their introduction would make some investors very rich, while sparking the $497.8 billion regenerative medicine boom next month.

But one question remains…

How exactly will “Bio Seeds” clear the FDA with such certainty – especially when FDA clearance normally takes 12 years and $350 million, according to Drugs.com?

Here’s the answer…

Bypassing the FDA –
Legally – Next Month

Instead of introducing “Bio Seeds” to the patient market first, the company will employ a unique “launch strategy.”

“Bio Seeds” will initially be available only to the global research market, which isn’t regulated by the FDA at all!

As Doctor X says:

“We are implementing a near-term revenue strategy by seeking to develop and market [Bio Seeds] that can be used by researchers at universities and biopharmaceutical companies.

“These research-only products generally can be marketed without regulatory (FDA) approval, and are therefore relatively near-term business opportunities when compared to human therapeutic products.”

And that’s how the company will bypass the FDA as soon as next month, making some investors very rich.

But why haven’t you heard about the coming event from CNBC, Jim Cramer, or The Wall Street Journal?

Because the company has signed a secret distribution deal with the most powerful pharmaceutical company on Earth…

This company has more than 30,000 employees and distribution channels in 64 countries.

According to our intelligence, the deal will finalize within the next six weeks.

When it does, “Bio Seeds” will storm past FDA approval and into dozens of markets worldwide, including the United States, Canada, Great Britain, China, India and Brazil.

Gains could come very fast. They could be sizable.

Market-Proof Gains of 15,306%… 22,168%… 77,955%

Consider how much investors have pocketed from similar product launches clearing the FDA…

• Celgene’s new cancer-treatment drug finally cleared the FDA. The stock soared 15,306%. During one rough patch in the markets, CELG rocketed 1,582% while the S&P lost 2.12%.
• Biogen cleared its new multiple-sclerosis drug through the FDA. Investors pocketed 21,168%. During a major 14.83% downturn in the broad market, BIIB soared 1,284%!
• Amgen’s human-protein therapy passed FDA trials, igniting a stock run of 77,955%. The run includes a period where AMGN soared 357.84% while the S&P tanked 12.81%.

And now, for the first time, you can be 100% certain a major breakthrough product will bypass the FDA.

That’s the opportunity we’re talking about with “Bio Seeds.” We’re just days away from this watershed event.

We’ve compiled a complete research report on this situation called Play the “New Medicine” Revolution for Maximum Gains.

It reveals everything you need to know, right down to the stock symbol.

You won’t pay a dime for this intelligence. Simply claim your copy right now, and I’ll rush it to you for free.

Here’s why we’re making this possible…

How to Claim All This Research for Free

My name is Robert Williams. I’ve spent years working as the lead financial analyst for a Forbes top-50 private corporation, but today I’m the publisher of a new kind of investment advisory letter called The White Cap Report.

Each month, our readers get the inside scoop on innovative small-cap companies long before they ever register a blip on Wall Street’s radar.

In short, our team isolates little companies doubling profits… operating in multi-billion dollar industries… with little or no competition.

Companies destined to soar higher no matter what’s happening with housing, the economy, or the stock market.

Companies like the California biotech behind “Bio Seeds”…

We track these companies in our White Cap Trading Portfolio – based on our proprietary “White Cap” evaluation system.

Since July 22, 2009, every position we closed last year was a winner.

In other words, we batted 1,000 and readers had the opportunity to book 315% gains. Just consider…

• On July 22, we booked 100% gains on ICGE.
• On July 24, we booked 102.61% gains on NVEC.
• On August 5, we booked 35.52% gains on ICUI.
• On August 5, we booked 30.87% gains on TSYS.
• On October 21, we booked 5.52% gains on ADPT.
• On October 28, we booked 41.37% gains on NVEC.

*Results are through December 21, 2009.

This year, the windfall has continued. Right now, we’re sitting on gains of…

• 34.7% in a small cancer-fighting biotech…
• 67.7% in a company revolutionizing American computer networks…
• 42.3% on a medical-service provider…
• 34.4% on a public-works engineering company…
• And countless smaller gains including… 24.9%… 16.73%… 21.79%… 14.44%… 26.8%… and 16.11%… the list goes on…

White Cap Report readers know we’re not cherry-picking here.

Again, The White Cap Trading Portfolio has been up over 300% since July 2009.

But we expect bigger returns from the tiny biotech company featured in Play the “New Medicine” Revolution for Maximum Gains.

In fact, the gains could be 10-times bigger, maybe more.

Quadruple-Digit Gains Like Clockwork

Finding quality small-cap stocks like this is no small task. But as you’ll see, our team consists of the world’s leading small-cap experts. People who helped readers cash-in on countless opportunities in 2009.

For example…

Keep in mind, timing these opportunities perfectly is critical. If you hesitate, you risk the chance of too many people getting in and share prices running up. You see, unlike ETFs, mutual funds and blue-chip stocks, as volume on penny stocks increases, shares can soar.

But you don’t have to worry about the details of how this strategy works, or the timing of when to make a trade – that’s our job.

Our research eliminates all the guesswork for you.

All you have to do is check your e-mail… get your simple instructions… decide if you want to follow the recommendations and how much you want to invest… and wait for the quadruple-digit gains to come in.

Then do it again… and again… and again.

And your first chance will come when you claim your free copy of our latest report, Play the “New Medicine” Revolution for Maximum Gains.

You’ll receive this report free, just for trying our research.

But there’s something else I’d like to send you free, too…

The American Penny
Stock That Could Save China

We’ve uncovered a tiny American energy company that could help China solve its energy crisis. And that crisis grows by the day…

According to the Harvard Asia Pacific Review, China adds the equivalent of the entire U.K. power grid each year.

The nation already stands as the world’s second-leading consumer of petroleum products, behind the United States.

Chinese energy consumption is growing 50% faster that GDP, according to Jeffrey Logan, Senior China Analyst for the International Energy Agency.

And the trend will only accelerate as China switches from a production economy to a consumption economy.

Consider… For every 1,000 citizens, China only has seven cars. In advanced countries, that number is 120 cars per 1,000 people – a 17-fold difference.

Meanwhile, the world’s oil supplies are tightening, as drillers move into dangerous offshore sites. Coal-fired power plants are blackening the skies over Beijing.

The perfect way to play China’s energy crisis would be a safe U.S. company… trading on a major exchange… that just hit a massive energy discovery behind the Great Wall.

And that’s exactly what our researchers just uncovered.

This micro-cap driller – which you will not hear about from your broker – has struck an estimated 3.8 trillion cubic feet of pure natural gas in China’s Ordos Basin.

According to independent LCH Surveys Limited, the find is worth $460 million. That’s 62 times the tiny energy company’s market cap!

The company is bringing this mother lode to market right now. And early investors will book at least 325% gains, according to our estimates.

You’ll find all the details of this tiny energy dynamo in another new report I’d like to send you.

It’s called Monster Discovery: Earn 325% on China’s Natural Gas Boom.

All you have to do is agree to take our small-cap research for a “test drive”…

Who We Are… And What We Can Do for You

At The White Cap Research Group, we believe everyone should have the opportunity to achieve great wealth. If you’re an investor, the amount of money in your account shouldn’t hinder the quality of research and recommendations you receive.

In short, our core belief is that everyone striving to amass great wealth should have an equal opportunity to do so.

And The White Cap Report is a great way to level the playing field and help you get rich.

You see, we specialize in finding under-the-radar investments, capable of handing you market-trouncing performance.

But as you can imagine, singling out these stocks takes time… and exhaustive research.

In fact, it typically takes us three to six months to identify the next small cap we believe is destined to ride a wave of institutional demand.

If you don’t have that kind of time, don’t worry…

Your Own Private Pipeline of Amazing Opportunities

As White Cap Report readers know, our team of experts and I do all the work for you.

Led by Investment Director, Louis Basenese, our progressive group includes three of the brightest minds in the financial markets today.

A world-renowned options expert once called a “Market Maven” by CNBC… a floor trader direct from the Chicago Mercantile Exchange… and a top analyst that any research firm would pay top dollar to get onboard…

Together, this group brings decades of experience to the White Cap team. And they deliver results to you every month in our fast-paced investment advisory letter called The White Cap Report.

As we speak we’re scouring earnings reports, talking with venture capitalists, private equity shops, and conducting on-the-ground due diligence on over 25 other potential opportunities.

Including…

• An under-the-radar geothermal power development and licensing technology company. Expected gains 123%.

“WHITE CAP” WINNER #8 “SRAM Technology” play set to explode! Estimated gain: 314% This tiny semiconductor company’s “SRAM” technology drastically boosts speeds of computers. Its chips are the fastest on the market and work at a mind-boggling nine nanoseconds. Its revenue doubled this quarter over last year and earnings have tripled. Its stock trades at just 15-times earnings, but it won’t stay this cheap for long. Demand for its lightning-fast semiconductors is set to soar.

• A manufacturer of the world’s most powerful lithium-ion batteries, capable of enabling hybrids to achieve 150 or more miles per gallon. Expected gains 67%.
• And a niche player in the online education space, with earnings growth of 268%. Expected gains 279%.

And the only way to find out about these stocks – and all future opportunities we uncover – is to get a subscription to The White Cap Report.

Reading The White Cap Report can help make you a much richer and smarter person.

Not to Brag, But Our Readers Are Getting Rich

But don’t take my word for it. Here are a few recent comments our readers just sent us…

“I am most impressed. I believe that this is a great strategy that will help everyone make timely decisions in a volatile market.”
– Alex O.

“Most of the time you guys are right on the money and I’m the one that has lost out on some of the opportunities (profits) by not totally believing in your picks. Keep on rocking because it’s making money for all of us.”
– AJF

“This is the best letter I have read in a long time.”
– Douglas H.

“Among the things I like about The White Cap Report is the continuous communications… and the picks are reasonably thought out… you’re hitting enough home runs to be Babe Ruth…”
– Tim D.

“I really appreciate you taking questions and answering the tough ones. I have been so frustrated over the years at newsletters where there is no way to get updated information or ask questions. You’re providing a great service.”
– Brenda

These are just a few of the hundreds of e-mails we get each month from our readers. Yes, we do get an occasional e-mail letting us know “how we can do better” but the majority of our letters read like these.

That’s because our readers get well-researched recommendations and have the opportunity to make more money than they could ever get from a TV “guru” or the financial papers.

They nailed 102% on a nanotechnology play…

They pocketed 47% on an unlikely solar trade…

They had the opportunity to make 35% on a disposable medical device company…

They also could have made 102% on a venture capital firm… There’s too many to list here.

My point is: The White Cap Report unearths companies long before they become mainstream news.

Before I give you details on how to get started, I’d like to tell you about some exciting technology companies we just uncovered…

Introducing the Three “Next Apples”…

Nothing drives a stock higher, faster than an innovative new technology. Indeed, estimates indicate that innovation accounts for 80% of productivity growth. And productivity accounts for 80% of Gross Domestic Product (GDP) growth.

The perfect example is Apple Inc. (Nasdaq: AAPL).

Its historic run of 1,952% began on October 23, 2001, when it released the most innovative device of our time – the iPod.

Like Apple, the companies we’ve just uncovered have innovative breakthrough technologies and are set to soar.

These are…

• “Tiny Tech” Titan #1:
  
  This company is an emerging “internet traffic” giant with $116 million in sales – a seven-fold increase in the last five years. Sales and earnings are hitting record-breaking levels, thanks to the massive demand for bandwidth. It supplies its “session border” technology to 48 of the top 50 internet service providers – enabling customers to transmit data seamlessly between different internet networks. We don’t expect its identity to remain a secret much longer, as shares could easily double to $20 in the coming months.
• “Tiny Tech” Titan #2:
  
  A software company with a $115 million market cap is the leader in a field that didn’t even exist a few years ago. Its electronic data capture and clinical data management systems help drug companies go digital. In short, its new technology fast-tracks clinical trials for drug companies. This is important because it reduces costly phase II trials by an average of 47% and phase III by 54%. With revenue over $50 million, a conservative balance sheet and a solid management team, this tiny company could soar 68% based on its price-to-sales ratio alone.
• “Tiny Tech” Titan #3:
  
  Microsoft maintained licensing rights to every operating system sold with its software. And it quickly became the richest company in America. Well, we’ve uncovered what could be the next Microsoft. But in this case, the company we found is the beneficiary of the major shift in communication to “mobile data transfer,” also called “text messaging.” It has relationships with AT&T, Sprint and Verizon, and gets a fraction of a penny for every text message sent. And this isn’t chump change. Last year its technology got a piece of over 200 billion messages. Text messaging increased 450% from just two years ago, and there’s no sign of slowing down. We’re confident shares could easily jump 125% before Wall Street even notices.

You’ll get all the details on each of these amazing opportunities in our special report: Finding the Next Apple: Three Tiny Technology Companies Set to Breakout.

I’ll also rush you this report for free when you decide to try our research.

Of course, you’ll get everything else I mentioned earlier, too.

Why This Opportunity May Not Be Right for You

Sorry for being blunt, but The White Cap Report is not for everyone.

We don’t recommend boring dividend-paying blue chips… or stodgy non-cyclical stocks… bonds… or classic value stocks.

That’s not our style…

Instead, we focus on unearthing the market’s fastest-growing, most cutting-edge companies. Companies suited for aggressive and opportunistic individuals only.

All of our plays trade exclusively on major exchanges… But they tend to be smaller, under-the-radar investments.

In other words, you won’t find our recommendations touted in the pages of The Wall Street Journal. Not yet at least.

So if you’re ready to invest in fast-moving small-caps, high-flying options and the most explosive penny stocks, one-step ahead of Wall Street, I encourage you to take advantage of this opportunity…

Not Just a Newsletter – A Roadmap to Wealth

When you agree to try The White Cap Report you’ll get a complete roadmap – with strategies and investment ideas – so you can build your wealth.

Here’s what your subscription includes:

• A confidential monthly report… Every month you’ll receive a new report, mailed and e-mailed to you, with the identity of the newest additions to our White Cap Trading Portfolio (months before Wall Street even has a clue).
• Weekly portfolio updates… These contain in-depth analysis and important updates on stocks in our model trading portfolio, plus insights into opportunities we are currently researching.
• Instant market updates… The minute a fast-moving development occurs, you’ll get an alert so you can lock-in profits or minimize losses.
• Private website access… You’ll get your own password so you can log-on to our private website anytime – day or night. Here you’ll find a comprehensive overview of our model portfolios, all of our recommendations and a constantly expanding library of special reports on specific, time-sensitive opportunities.
• The popular Smash Hit or Trash It! e-letter… One of our most popular broadcasts among subscribers. In it, we give a fast-paced breakdown of stocks that subscribers send in. Then we offer our opinion on whether they represent a worthwhile investment or should be thrown on the scrap heap.
• The White Cap Mailbag… This is where you’ll find our answers to subscribers’ questions, which may be ones you’ve been asking yourself. And, for the record, we don’t dodge the hard questions. Here you’ll have the opportunity to e-mail the White Cap team with questions on stocks, the markets, or our recommendations.
• And more…

The time to put your money to work and make up for previous losses is right now – and that’s why you should at least try The White Cap Report today.

And we reduced the price to just $99 per year.

I think you’ll agree this is a great offer.

But I want to make this a complete no-brainer for you…

Join Today and Risk Nothing

I know there’s a lot of “hype” in the newsletter industry. Many of our colleagues make big promises, only to under deliver. We truly are different… and I don’t want you to take my word for it.

Reader Diane Stevens from Avon, CO, puts it best:

“I just thought I should drop a line to say what a great job your team is doing. This is really the best reporting I have seen. It is current and thorough. I have more confidence in White Cap than other reports whose “experts” seem to be wandering in a fog. Moreover, I am making more profits as I write. Your alerts are right on!”

So here’s what I’m doing: Claim your subscription and all of the reports and research, everything.

Then take 45 days to decide if this newsletter and our research is right for you. If you’re not thrilled, simply contact our Client Services Group within 45 days and receive a full refund.

But here’s the thing, even if you decide this is not right for you, you keep everything…

YOU KEEP: Special Report #1 – Play the “New Medicine” Revolution for Maximum Gains

YOU KEEP: Special Report #2 – Monster Discovery: Earn 325% on China’s Natural Gas Boom

YOU KEEP: Special Report #3 – Finding The Next Apple: Three Tiny Technology Companies Set to Breakout

But there’s another reason to act fast.

Limited to the First 500 Readers Who Respond

The intelligence we’re sending you pertains to all small-cap companies. If too many investors pile in at the same time, shares could soar. And we’re not in business to move stocks.

That’s why we are only accepting the first 500 readers who respond to this offer.

If you wait, this offer will be gone.

So if you’re interested in discovering the California company about to change medicine forever…

Or the tiny American energy firm poised to solve China’s energy crisis…

Or the three firms most likely to become the “next Apple”…

Please click here now and follow the simple instructions.

Or if you’d prefer to speak with a live person, please call 866.444.1556 or 630.585.2795 and mention Priority Code: WWCXL901.

We’ll rush you your Welcome Kit right away, and give you access to the reports immediately.

I look forward to having you onboard for a profitable year ahead.

Sincerely,

Robert Williams
Publisher
The White Cap Report

P.S. Remember, the tiny California biotech is poised to storm the markets with its “Bio Seeds” product next month! Time is of the essence… and gains could surpass 22,627% for early investors. Please CLICK HERE right away for instant access to our full intelligence on this fast-moving opportunity.

P.P.S. Keep in mind, this offer has a strict limit. We are only accepting the first 500 readers who respond to today’s offer. Don’t wait another minute, it could mean missing out on life-changing returns. Simply CLICK HERE to take advantage of this opportunity now.

P.P.S. Remember, we are so convinced that The White Cap Report will boost your wealth by 10-times… that if you are not 100% thrilled, you have 45 days to get a prompt and full refund. That way, you risk nothing. CLICK HERE now and all of the reports and research you receive is yours to keep for giving this a try.